Data integration: Challenges for drug discovery

Nature Reviews Drug Discovery

Volumn 4, Issue 1, 2005, Pages 45-58

  Searls, David B ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

COMPUTER PROGRAM; DATA ANALYSIS; DATA BASE; DECISION SUPPORT SYSTEM; DRUG DETERMINATION; DRUG RESEARCH; ECONOMIC ASPECT; GENETIC ANALYSIS; INFORMATION PROCESSING; METHODOLOGY; PRIORITY JOURNAL; REVIEW; SEMANTICS; TECHNOLOGY;

DATA COLLECTION; DATABASE MANAGEMENT SYSTEMS; DRUG DESIGN; DRUG INDUSTRY; MODELS, THEORETICAL; SYSTEMS INTEGRATION; TERMINOLOGY;

EID: 12144262660     PISSN: 14741776     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrd1608     Document Type: Review

References (178)

1. Venkatesh, T. V. & Harlow, H. B. Integromics: challenges in data integration. Genome Biol. 3, reports4027.1-4027.3 (2002).
2. Hodgson, J. Reconstructing pharmaceutical instinct. Nature Biotechnol. 20, 1199-1203 (2002).
3. Reichhardt, T. It's sink or swim as a tidal wave of data approaches. Nature 399, 517-520 (1999).
4. Ball, P. The speed of computers. Nature 402, C61 (1999).
5. Wise, J. An information bank? Curr. Drug Disc. Feb 9-10 (2003).
6. Wong, L. Technologies for Integrating biological data. Brief. Bioinform. 3, 389-404 (2002).
7. Stein, L. D. Integrating biological databases. Nature Rev. Genet. 4, 337-345 (2003).
8. Eckman, B. A. in Bioinformatics: Managing Scientific Data (eds Lacroix, Z. & Critchlow, T.) 35-74 (Morgan Kaufmann, San Francisco, 2003).
9. Golden, J. Towards a tractable genome: knowledge management in drug discovery. Curr. Drug Disc. Feb, 17-20 (2003).
10. Ficenec, D. et al. Computational knowledge integration in biopharmaceutical research. Brief. Bioinform. 4, 260-278 (2003).
11. Choi, J. K. et al. Integrative analysis of multiple gene expression profiles applied to liver cancer study. FEBS Lett. 565, 93-100 (2004).
12. Smalheiser, N. R. Informatics and hypothesis-driven research. EMBO Rep. 3, 702 (2002).
13. Weinstein, J. N. 'Omic' and hypothesis-driven research in the molecular pharmacology of cancer. Curr. Opin. Pharmacol. 2, 361-365 (2002).
14. Hui, G., Walhout, A. J. M. & Vidal, M. Integrating 'omic' information: a bridge between genomics and systems biology. Trends Genet. 19, 551-560 (2003).
15. Boguski, M. S. & McIntosh, M. W. Biomedical informatics for proteomics. Nature 422, 233-237 (2003).
16. Hallgren, E., Palmer, M. W. & Milberg, P. Data diving with cross validation: an investigation of broad-scale gradients in Swedish weed communities. J. Ecol. 87, 1037-1051 (1999).
17. Smith, G. D. & Ebrahim, S. Data dredging, bias, or confounding. B. M. J. 325, 1437-1438 (2002).
18. Tilstone, C. DNA microarrays: vital statistics. Nature 424, 610-612 (2003).
19. Reiner, A., Yekutieli, D. & Benjamini, Y. Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics 19, 368-375 (2003).
20. McShane, L. M., Radmacher, M. D., Freidlin, B., Yu, R., Li, M. C. & Simon, R. Methods for assessing reproducibility of clustering patterns observed in analyses of microarray data. Bioinformatics 18, 1462-1469 (2002).
21. Simon, R., Radmacher, M. D., Dobbin, K. & McShane, L. M. Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification. J. Natl. Cancer Inst. 95, 14-18 (2003).
22. Potter, J. D. At the interfaces of epidemiology, genetics and genomics. Nature Rev. Genet. 2, 142-147 (2001).
23. Glymour, C., Madigan, D., Pregibon, D. & Smyth, P. Statistical themes and lessons for data mining. Data Mining Knowledge Disc. 1, 11-28 (1997).
24. Quackenbush, J. Microarray data normalization and transformation. Nature Genet. 32, 496-501 (2002).
25. Rajagopalan, D. A comparison of statistical methods for analysis of high density oligonucleotide array data. Bioinformatics 19, 1460-1476 (2003).
26. Kuo, W. P., Janssen, T. K., Butte, A. J., Ohno-Machado, L. & Kohane, I. S. Analysis of matched mRNA measurements from two different microarray technologies. Bioinformatics 18, 405-412 (2002).
27. Churchill, G. A. Fundamentals of experimental design for cDNA microarrays. Nature Genet. 32 suppl, 490-495 (2002).
28. Yang, Y. H. et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res. 30, e15 (2002).
29. Ideker, T., Thorsson, V., Siegel, A. F. & Hood, L. E. Testing for differentially-expressed genes by maximum-likelihood analysis of microarray data. J. Comput. Biol. 7, 805-817 (2000).
30. Pan, W. A comparative review of statistical methods for discovering differentially expressed genes in replicated microarray experiments. Bioinformatics 18, 546-554 (2002).
31. Wolfinger, R. D. et al. Assessing gene significance from cDNA microarray expression data via mixed models. J. Comput Biol. 8, 625-637 (2001).
32. Egger, M., Smith, G. D. & Phillips, A. N. Meta-analysis: principles and procedures. Brit. Med. J. 315, 1533-1537 (1997).
33. Cooper, H. & Hedges, L. V. (eds.) The Handbook of Research Systhesis (Russell Sage Foundation, New York NY, 1994).
34. Thomas, D. C. The problem of multiple inference in studies designed to generate hypotheses. Am. J. Epidemiol. 122, 1080-1095 (1985).
35. Perneger, T. V. What's wrong with Bonferroni adjustments. Brit. Med. J. 316, 1236-1238 (1998).
36. Bender, R. & Lange, S. Multiple test procedures other than Bonferroni's deserve wider use. Brit. Med. J. 318, 600 (1999).
37. Rhodes, D. R., Barrette, T. R., Rubin, M. A., Ghosh, D. & Chinnalyan, A. M. Meta-analysis of microarrays: interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer. Cancer Res. 62, 4427-4433 (2002).
38. Stanton, J. L. & Green, D. P. Meta-analysis of gene expression in mouse preimplantation embryo development. Mol. Hum. Reprod. 7, 545-552 (2001).
39. Callow, M. J., Dudoit, S., Gong, E. L., Speed, T. P. & Rubin, E. M. Microarray expression profiling identifies genes with altered expression in HDL-deficient mice. Genome Res. 10, 2022-2029 (2000).
40. Tusher, V. G., Tibshirani, R. & Chu, G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 98, 5116-5121 (2001).
41. Aitchison, J. D. & Galitski, T. Inventories to insights. J. Cell Biol. 161, 465-469 (2003).
42. Choi, J. K. et al. Integrative analysis of multiple gene expression profiles applied to liver cancer study. FEBS Lett. 565, 93-100 (2004).
43. Jiang, H. et al. Joint analysis of two microarray gene-expression data sets to select lung adenocarcinoma marker genes. BMC Bioinformatics 5, 81 (2004).
44. Stone, J. V. Independent component analysis: an introduction. Trends Cog. Sci. 6, 59-64 (2002).
45. Saidi, S. A. et al. Independent component analysis of microarray data in the study of endometrial cancer. Oncogene 23 6677-6683 (2004).
46. Schum, D. A. The Evidential Foundations of Probabilistic Reasoning (Wiley-Interscience, New York, 1994).
47. Pearl, J. Causality: Models, Reasoning, and Inference (Cambridge Univ. Press, Cambridge, UK, 2000).
48. Hinneburg, A. & Keim, D. A. In Proceedings of the 25th International Conference on Very Large Data Bases (eds Atkinson, M. P., Orlowska, M. E., Valduriez, P., Zdonik, S. B. & Brodie, M. L.) 506-517 (Morgan Kaufmann, San Francisco, 1999).
49. Halpin, T. Information Modeling and Relational Databases (Academic Press, San Diego, 2001).
50. Spence, R. Information Visualization (ACM Press, 2001).
51. Tufte, E. R. The Visual Display of Quantitative Information. Second Edition. (Graphics Press, Cheshire CT, 2001).
52. Hierarchical and Geometrical Methods in Scientific Visualization. Farin, G. E., Hamann, B. & Hagen, H., eds. (Springer Verlag, 2003).
53. Weber, R., Schek, H. & Blott, S. A quantitative analysis and performance study for similarity search methods in high dimensional spaces. In Proceedings of the 24th International Conference on Very Large Data Bases (VLDB) pp. 194-205 (Morgan Kaufmann, San Francisco CA, 1998).
54. Bellman, R. Adaptive Control Processes: A Guided Tour (Princeton University Press, Princeton NJ, 1961).
55. Indyk, F. & Motwani, R. Approximate nearest neighbors: Towards removing the curse of dimensionality. In Proc. of the 30th ACM Symp. on Theory of Computing, pp. 604-612, (Addison Wesley, Boston MA, 1998).
56. Jungnickel, D. Graphs, Networks, and Algorithms (Springer Verlag, Berlin, 1999).
57. Li, S. et al. A map of the interactome network of the metazoan C. elegans. Science 303, 540-543 (2004).
58. Toyoda, T., Mochizuki, Y. & Konagaya, A. GSCope: a clipped fisheye viewer effective for highly complicated biomolecular network graphs. Bioinformatics 19, 437-438 (2003).
59. Searls, D. B. Data integration - connecting the dots. Nature Biotechnol. 21, 844-845 (2003).
60. Searls, D. B. Pharmacophylogenomics: genes, evolution and drug targets. Nature Rev. Drug Discov. 2, 613-623 (2003).
61. Wooley J. C. Trends in computational biology. J. Comp. Biol. 6, 459-474 (1999).
62. Grunling, C. et al. Dyslexia: the possible benefit of multimodal integration of fMRI- and EEG-data. J. Neural Transm. 111, 951-969 (2004).
63. Rector, A. L., Rogers, J., Roberts, A. & Wroe, C. Scale and context: issues in ontologies to link health- and bioinformatics. Proc. AMIA Symp. 642-646 (2002).
64. Gund, P., Dippolito, M. & Shimshock, Y. Much ado about data. Curr. Drug Disc. Feb 29-32 (2003).
65. Bredel, M. & Jacoby, E. Chemogenomics: an emerging strategy for rapid target and drug discovery. Nature Rev. Genet. 5, 262-275 (2004).
66. Shah, S. P. et al. Pegasys: software for executing and integrating analyses of biological sequences. BMC Bioinformatics 5, 40 (2004).
67. Huminiecki, L., Lloyd, A. T. & Wolfe, K. H. Congruence of tissue expression profiles from Gene Expression Atlas, SAGEmap and TissueInfo databases. BMC Genomics 4, 31 (2003).
68. Bader, G. D. & Hogue, C. W. V. Analyzing yeast protein-protein interaction data obtained from different sources. Nature Biotech. 20, 991-997 (2002).
69. Eisen, M. B., Spellman, P. T., Brown, P. O. & Botstein, D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 95, 14863-14868 (1998).
70. Blower, P. E. et al. Pharmacogenomic analysis: correlating molecular substructure classes with microarray gene expression data. Pharmacogenomics J. 2, 259-271 (2002).
71. Yeger-Lotem, E. & Margalit, H. Detection of regulatory circuits by integrating the cellular networks of protein-protein interactions and transcription regulation. Nucleic Acids Res. 31 6053-6061 (2003).
72. Lee, S. G., Hur, J. U. & Kim, Y. S. A graph-theoretic modeling on GO space for biological interpretation of gene clusters. Bioinformatics 20, 381-388 (2004).
73. Jansen, R. et al. A Bayesian networks approach for predicting protein-protein interactions from genomic data. Science 302, 449-453 (2003).
74. Troyanskaya, O. G., Dolinski, K., Owen, A. B., Altman, R. B., & Botstein, D. A Bayesian framework for combining heterogeneous data sources for gene function prediction (in Saccharomyces, cerevisiae . Proc. Natl. Acad. Sci. USA 100, 8348-8353 (2003).
75. Imoto, S. et al. Use of gene networks for identifying and validating drug targets. J. Bioinform. Comput. Biol. 1, 459-474 (2003).
76. Alm, E. & Arkin, A. P. Biological networks. Curr. Opin. Struct. Biol. 13, 193-202 (2003).
77. Barabasi, A. L. & Oltvai, Z. N. Network biology: understanding the cell's functional organization. Nature Rev. Genet. 5, 101-113 (2004).
78. Yeger-Lotem, E. & Margalit, H. Detection of regulatory circuits by integrating the cellular networks of protein-protein interactions and transcription regulation. Nucleic Acids Res. 31 6053-6061 (2003).
79. Stelling J., Klamt, S., Bettenbrock, K., Schuster, S. & Gilles, E. D. Metabolic network structure determines key aspects of functionality and regulation. Nature 420, 190-193 (2002).
80. Kohler, J. & Schulze-Kremer, S. The semantic metadatabase (SEMEDA): ontology based integration of federated molecular biological data sources. In Silico Biol. 2, 219-231 (2002).
81. Kerr, R. A. English-metric miscue doomed Mars mission. ScienceNOW (American Association for the Advancement of Science) 30 Sept (1999).
82. Hegde, P. S., White, I. R. & Debouck, C. Interplay of transcriptomics and proteomics. Curr. Opin. Biotechnol. 14, 647-651 (2003).
83. Spellman, P. T. et al. Design and implementation of microarray gene expression markup language (MAGE-ML) Genome Biol. 3, RESEARCH0046 (2002).
84. Brazma, A. et al. Minimum Information About a Microarray Experiment (MIAME)-toward standards for microarray data. Nature Genet 29, 365-371 (2001).
85. Hermjakob, H. et al. The HUPO PSI's molecular interaction format-a community standard for the representation of protein interaction data. Nature Biotechnol. 22, 177-183 (2004).
86. Wain, H. M., et al. Genew: the human gene nomenclature database. Nucl. Acids Res. 30, 169-171 (2002).
87. Pruitt, K. D. & Maglott, D,R. RefSeq and LocusLink: NCBI gene-centered resources. Nucl. Acids Res. 29, 137-140 (2001).
88. Clark, T., Martin, S. & Liefeld, T. Globally distributed object identification for biological knowledgebases. Brief. Bioinform. 5, 59-70 (2004).
89. Ashburner, M. & Lewis, S. On ontologies for biologists: the Gene Ontology - untangling the web. Novartis Found. Symp. 247 66-80 (2002).
90. Stevens, R., Goble, C. A. & Bechhofer, S. Ontology-based knowledge representation for bioinformatics. Brief. Bioinform. 1 398-414 (2000).
91. Bard, J. B. L. & Rhee, S. Y. Ontologies in biology: design, applications and future challenges. Nature Rev. Genet. 5, 213-222 (2004).
92. Demir, E. et al. An ontology for collaborative construction and analysis of cellular pathways. Bioinformatics 20, 349-356 (2004).
93. Roux-Rouquie, M., Caritey N., Gaubert, L. & Rosenthal-Sabroux, C. Using the Unified Modelling Language (UML) to guide the systemic description of biological processes and systems. Biosystems 75, 3-14 (2004).
94. Campagne, F. et al. Quantitative information management for the biochemical computation of cellular networks. Sci. STKE 2004, 1-12 (2004).
95. Gault, L. V., Shultz, M. & Davies, K. J. Variations in Medical Subject Headings (MeSH) mapping: from the natural language of patron terms to the controlled vocabulary of mapped lists. J. Med. Libr. Assoc. 90, 173-180 (2002).
96. Blake, J. Bio-ontologies - fast and furious. Nature Biotechnol 22, 773-774 (2004).
97. Rothwell, D. J. SNOMED-based knowledge representation. Methods Inf. Med. 34, 209-213 (1995).
98. Burgun, A., Botti, G., Fieschi, M. & Le Beux, P. Issues in the design of medical ontologies used for knowledge sharing. J. Med. Syst. 25, 95-108 (2001).
99. Martin-Sanchez, F., Maojo, V. & Lopez-Campos, G. Integrating genomics into health information systems. Methods Inf. Med. 41 25-30 (2002).
100. Stevens, R. et al. TAMBIS: transparent access to multiple bioinformatics information sources. Bioinformatics 16 184-185 (2000).
101. Kohler, J., Philippi, S. & Lange, M. SEMEDA: ontology based semantic integration of biological databases. Bioinformatics 19 2420-2427 (2003).
102. Woods, W. A. Important issues in knowledge representation. Proc. IEEE 74, 1322-1334 (1986).
103. McGuinness, D. L. & Patel-Schneider, P. F. in Proc. 15th Nature Conf. on Artificial Intelligence, pp. 608-614 (AAAI Press, Menlo Park, 1998).
104. Kohane, I. S. Bioinformatics and clinical informatics: the imperative to collaborate. J. Am. Med. Inform. Assoc. 7, 512-516 (2000).
105. Tsuji, N. Selection of an internal control gene for quantitation of mRNA in colonic tissues. Anticancer Res. 22, 4173-4178 (2002).
106. Tricarico C., et al. Quantitative real-time reverse transcription polymerase chain reaction: normalization to rRNA or single housekeeping genes is inappropriate for human tissue biopsies. Anal. Biochem. 309, 293-300 (2002).
107. Turban, E. & Aronson, J. E. Decision Support Systems and Intelligent Systems 6th Edition (Prentice-Hall, Upper Saddle River, 2000).
108. Norvig, P. PowerPoint: shot with its own bullets. Lancet 362, 343-344 (2003).
109. Tufte, E. R. The Cognitive Style of PowenPoint(Graphics Press, Cheshire, 2003).
110. Von Halle, B. Business Rules Applied (John Wiley & Sons, New York, 2001).
111. Berry, M. J. A. & Linoff, G. Data Mining Techniques (John Wiley & Sons, New York, 1997).
112. Tanabe, L. & Wilbur, W. J. Tagging gene and protein names in biomedical text. Bioinformatics 18, 1124-1132 (2002).
113. Boffetta, P. Molecular epidemiology. J. Intern. Med. 248, 447-454 (2000).
114. Konyndyk, K. Introductory Modal Logic (Univ. of Notre Dame Press, Notre Dame, 1986).
115. Blom, J. A. Temporal logics and real time expert systems. Comput. Methods Programs Biomed. 51, 35-49 (1996).
116. Parascandola, M. & Weed, D. L. Causation in epidemiology. J. Epidemiol. Community Health 55, 905-912 (2001).
117. Weed, D. L. Environmental epidemiology: basics and proof of cause-effect. Toxicology 181-182, 399-403 (2002).
118. Minker, J. in Proc. 6th Conf on Automated Deduction (Lecture Notes in Computer Science 138) 292-308 (Springer, New York NY, 1982).
119. Zaniolo, C. Database relations with null values. J. Comput. and Systems Sci. 29, 142-166 (1984).
120. Searls, D. B. Mining the bibliome. Pharmacogenomics J. 1, 88-89 (2001).
121. Brandt, C. A. et al. Metadata-driven creation of data marts from an EAV-modeled clinical research database. Int. J. Med. Inf. 65, 225-241 (1997).
122. Nadkarni, P. M. QAV: querying entity-attribute-value metadata in a biomedical database. Comput. Methods Programs Biomed. 53 93-103 (1997).
123. Nadkarni, P. M., Marenco, L., Chen, R., Skoufos, E., Shepherd, G. & Miller, P. Organization of heterogeneous scientific data using the EAV/CR representation. J. Am. Med. Inform. Assoc. 6 478-493 (1999).
124. Tavazoie, S. et al. Systematic determination of genetic network architecture. Nature Genet. 22, 281-285 (1999).
125. Fink, J. L. et al. 2HAPI: a microarray data analysis system. Bioinformatics 19, 1443-1445 (2003).
126. Roven, C. & Bussemaker, H. J. REDUCE: An online tool for inferring cis-regulatory elements and transcriptional module activities from microarray data. Nucleic Acids Res. 31, 3487-3490 (2003).
127. Coessens, B. et al. INCLUSive: a web portal and service registry for microarray and regulatory sequence analysis. Nucleic Acids Res. 31, 3468-3470 (2003).
128. Tong, A. H. et al. A combined experimental and computational strategy to define protein interaction networks for peptide recognition modules. Science 295, 321-324 (2002).
129. Ettwiller, L. M., Rung, J. & Birney E. Discovering novel cis-regulatory motifs using functional networks. Genome Res. 13 883-895 (2003).
130. Reiss, D. J. & Schwikowski, B. Predicting protein-peptide interactions via a network-based motif sampler. Bioinformatics 20, 1274-1282 (2004).
131. Obenauer, J. C. & Yaffe, M. B. Computational prediction of protein-protein interactions. Methods Mol. Biol. 261, 445-468 (2004).
132. Steffen, M. et al. Automated modelling of signal transduction networks. BMC Bioinformatics 3, 34 (2002).
133. Jansen, R., Lan, N., Qian, J. & Gerstein, M. Integration of genomic datasets to predict protein complexes in yeast. J. Struct. Funct. Genomics 2, 71-81 (2002).
134. Zhang, L. V., Wong, S. L., King, O. D. & Roth, F. P. Predicting co-complexed protein pairs using genomic and proteomic data integration. BMC Bioinformatics 5, 38 (2004).
135. Simpson, J. C., Wellenreuther, R., Poustka, A., Pepperkok, R. & Wiemann, S. Systematic subcellular localization of novel proteins identified by large-scale cDNA sequencing. EMBO Rep. 1, 287-292 (2000).
136. Del Val, C. et al. High-throughput protein analysis integrating bioinformatics and experimental assays. Nucleic Acids Res. 32, 742-748 (2004).
137. Morley, M. et al. Genetic analysis of genome-wide variation in human gene expression. Nature 430, 743-747 (2004).
138. Wang, J., Williams, R. W. & Manly, K. F. WebQTL: web-based complex trait analysis. Neuroinformatics 1, 299-308 (2003).
139. Pazos, F., Helmer-Citterich, M., Ausiello, G. & Valencia, A. Correlated mutations contain information about protein-protein interaction. J. Mol. Biol. 271, 511-523 (1997).
140. Kim, W. K., Bolser, D. M. & Park, J. H. Large-scale co-evolution analysis of protein structural interlogues using the global protein structural interactome map (PSIMAP). Bioinformatics 20 1138-1150 (2004).
141. Afonnikov, D. A. & Kolchanov, N. A. CRASP: a program for analysis of coordinated substitutions in multiple alignments of protein sequences. Nucleic Acids Res. 32, W64-W68 (2004).
142. Tan, S. H., Zhang, Z. & Ng, S. K. ADVICE: Automated Detection and Validation of Interaction by Co-Evolution. Nucleic Acids Res. 32, W69-W72 (2004).
143. Zhang, Z. & Ng, S. K. InterWeaver: interaction reports for discovering potential protein interaction partners with online evidence. Nucleic Acids Res. 32, W73-W75 (2004).
144. Vieth, M., Higgs, R. E., Robertson, D. H., Shapiro, M., Gragg, E. A. & Hemmerle, H. Kinomics-structural biology and chemogenomics of kinase inhibitors and targets. Biochim. Biophys. Acta 1697 243-257 (2004).
145. Giaever, G. et al. Chemogenomic profiling: identifying the functional interactions of small molecules in yeast. Proc. Nature Acad. Sci. USA 101, 793-798 (2004).
146. Mestres, J. Computational chemogenomics approaches to systematic knowledge-based drug discovery. Curr. Opin. Drug Discov. Devel. 7, 304-313 (2004).
147. Gunther, E. C., Stone, D. J., Gerwien, R. W., Bento, P. & Hayes, M. P. Prediction of clinical drug efficacy by classification of drug-induced genomic expression profiles in vitro. Proc. Natl. Acad. Sci. USA 100, 9608-9613 (2003).
148. Blower, F. E. et al. Pharmacogenomic analysis: correlating molecular substructure classes with microarray gene expression data. Pharmacogenomics J. 2, 259-271 (2002).
149. Pinhasov, A. et al. Gene expression analysis for high throughput screening applications. Comb. Chem. High Throughput Screen. 7, 133-140 (2004).
150. Veselovsky, A. V. et al. Protein-protein interactions: mechanisms and modification by drugs. J. Mol. Recognit. 15, 405-422 (2002).
151. Zeng, J. Mini-review: computational structure-based design of inhibitors that target protein surfaces. Comb. Chem. High Throughput Screen. 3, 355-362 (2000).
152. Wall, M. E., Rechtsteiner, A. & Roche, L. M. in A Practical Approach to Microarray Data Analysis (ed. Berrar, D. P., Dubitzky, W. & Granzow, M.) 91-109 (Kluwer, Norwell MA, 2003).
153. Kasprzyk, A. et al. EnsMart: a generic system for fast and flexible access to biological data. Genome Res. 14, 160-169.
154. Lenhard, B., Hayes, W. S. & Wasserman, W. W. GeneLynx: a gene-centric portal to the human genome. Genome Res. 11, 2151-2157.
155. Safran, M. et al. GeneCards 2002: towards a complete, object-oriented, human gene compendium. Bioinformatics 18, 1542-1543.
156. Tsai, J. et al. RESOURCERER: annotating and linking microarray resources within and across species. Genome Biol. 2 software0002.1-0002.4 (2001).
157. O'Neil, M. J. et al. The Merck Index (13th edition). (Merck & Co., Rahway NJ, 2001).
158. Mootha, V. K. et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nature Genet. 34, 267-273 (2003).
159. Al-Shahrour, F., Díaz-Uriarte, R. & Dopazo, J. FatiGO: a web tool for finding significant associations of Gene Ontology terms with groups of genes. Bioinformatics 20, 578-580 (2004).
160. Zeeberg, B. R. et al. GoMiner: a resource for biological interpretation of genomic and proteomic data. Genome Biol. 4, R28.
161. Berriz, G. F. King, O. D., Bryant, B., Sander, C. & Roth, F. P. Characterizing gene sets with FuncAssociate. Bioinformatics 19, 2502-2504 (2003).
162. Barriot, R. et al. New strategy for the representation and the integration of biomolecular knowledge at a cellular scale. Nucleic Acids Res. 32, 3581-3589 (2004).
163. Yu, H., Hatzivassiloglou, V., Rzhetsky, A. & Wilbur, W.J. Automatically identifying gene/protein terms in MEDLINE abstracts. J. Biomed. Inform. 35, 322-330 (2002).
164. Becker, K. G. et al. PubMatrix: a tool for multiplex literature mining. BMC Bioinformatics 4, 61.
165. Giuliano, K. A., Haskins, J. R. & Taylor, D. L. Advances in high content screening for drug discovery. Assay Drug Dev. Technol. 1, 565-577 (2003).
166. Jenssen, T. K., Laegraid, A., Komorowski, J. & Hovig, E. A literature network of human genes for high-throughput analysis of gene expression. Nature Genet. 28, 21-28 (2001).
167. Wilbur, W. J. et al. Analysis of biomedical text for chemical names: a comparison of three methods. Proc. AMIA Symp. 176-180 (1999).
168. Singh, S. B., Hull, R. D. & Fluder, E. M. Text Influenced Molecular Indexing (TIMI): a literature database mining approach that handles text and chemistry. J. Chem. Inf. Comput. Sci. 43, 743-752 (2003).
169. Dennis, G. Jr. et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 4, P3.
170. Dahlquist, K. D., Salomonis, N., Vranizan, K., Lawlor, S. C. & Conklin, B. R. GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nature Genet. 31, 19-20.
171. Bugrim A, Nikolskaya T, Nikolsky Y. Early prediction of drug metabolism and toxicity: systems biology approach and modeling. Drug Discov. Today 9, 127-135 (2004).
172. Tatusov, R. L. et al. The COG database: an updated version includes eukaryotes. BMC Bioinformatics 4, 41 (2003).
173. Li, L., Stoeckert, C. J. Jr. & Roos, D. S. OrthoMCL: identification of ortholog groups for eukaryotic genomes. Genome Res. 13, 2178-2189 (2003).
174. Lee, Y. et al. Cross-referencing eukaryotic genomes: TIGR Orthologous Gene Alignments (TOGA). Genome Res. 12, 493-502 (2002).
175. Kent, W. J. et al. The human genome browser at UCSC. Genome Res. 12, 996-1006 (2002).
176. Birney E. et al. Ensembl 2004. Nucleic Acids Res. 32, D468-D470 (2004).
177. Roignant, J. Y. et al. Absence of transitive and systemic pathways allows cell-specific and isoform-specific RNAi in Drosophila. RNA 9, 299-308 (2003).
178. Wuchty, S. Interaction and domain networks of yeast. Proteomics 2, 1715-1723 (2002).